388 related articles for article (PubMed ID: 26911419)
1. α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.
Inden M; Takata K; Yanagisawa D; Ashihara E; Tooyama I; Shimohama S; Kitamura Y
Neurochem Int; 2016 Mar; 94():74-81. PubMed ID: 26911419
[TBL] [Abstract][Full Text] [Related]
2. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
3. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
Yanagida T; Takeuchi H; Kitamura Y; Takata K; Minamino H; Shibaike T; Tsushima J; Kishimoto K; Yasui H; Taniguchi T; Shimohama S
Neurosci Res; 2008 Dec; 62(4):254-61. PubMed ID: 18845194
[TBL] [Abstract][Full Text] [Related]
5. A role for α4(non-α6)* nicotinic acetylcholine receptors in motor behavior.
Soll LG; Grady SR; Salminen O; Marks MJ; Tapper AR
Neuropharmacology; 2013 Oct; 73():19-30. PubMed ID: 23688922
[TBL] [Abstract][Full Text] [Related]
6. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of rotational behavior induced by repeated administration of SKF38393 in rats with unilateral nigrostriatal 6-OHDA lesions.
Matsuda H; Hiyama Y; Terasawa K; Watanabe H; Matsumoto K
Pharmacol Biochem Behav; 1992 Jun; 42(2):213-8. PubMed ID: 1385877
[TBL] [Abstract][Full Text] [Related]
8. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
Schilström B; Ivanov VB; Wiker C; Svensson TH
Neuropsychopharmacology; 2007 Jan; 32(1):43-53. PubMed ID: 16641937
[TBL] [Abstract][Full Text] [Related]
9. Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.
McCallum SE; Parameswaran N; Bordia T; McIntosh JM; Grady SR; Quik M
Mol Pharmacol; 2005 Sep; 68(3):737-46. PubMed ID: 15933214
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
Huang KX; Bergstrom DA; Ruskin DN; Walters JR
Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
Robertson GS; Fine A; Robertson HA
Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
[TBL] [Abstract][Full Text] [Related]
12. Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.
Rode F; Munro G; Holst D; Nielsen EØ; Troelsen KB; Timmermann DB; Rønn LC; Grunnet M
Brain Res; 2012 Jun; 1458():67-75. PubMed ID: 22552114
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
Jiang HK; McGinty JF; Hong JS
Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
[TBL] [Abstract][Full Text] [Related]
14. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
Pollack AE; Thomas LI
Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
[TBL] [Abstract][Full Text] [Related]
15. Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems.
Noda Y; Mouri A; Ando Y; Waki Y; Yamada SN; Yoshimi A; Yamada K; Ozaki N; Wang D; Nabeshima T
Int J Neuropsychopharmacol; 2010 Nov; 13(10):1343-54. PubMed ID: 20219155
[TBL] [Abstract][Full Text] [Related]
16. 3-[(2,4-Dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats.
Suzuki S; Kawamata J; Matsushita T; Matsumura A; Hisahara S; Takata K; Kitamura Y; Kem W; Shimohama S
J Neurosci Res; 2013 Mar; 91(3):462-71. PubMed ID: 23239187
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats.
Pollack AE; Fink JS
Brain Res; 1996 Dec; 743(1-2):124-30. PubMed ID: 9017239
[TBL] [Abstract][Full Text] [Related]
18. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
19. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour.
Robertson HA; Peterson MR; Murphy K; Robertson GS
Brain Res; 1989 Dec; 503(2):346-9. PubMed ID: 2532558
[TBL] [Abstract][Full Text] [Related]
20. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
Carlson JH; Bergstrom DA; Demo SD; Walters JR
Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
